Little Green Pharma Ltd Share Price

Equities

LGP

AU0000074924

Pharmaceuticals

Market Closed - Australian S.E. 11:40:45 26/04/2024 am IST 5-day change 1st Jan Change
0.125 AUD -3.85% Intraday chart for Little Green Pharma Ltd -7.41% -10.71%

Financials

Sales 2024 * 25.6M 16.72M 1.39B Sales 2025 * 29.8M 19.47M 1.62B Capitalization 37.69M 24.62M 2.05B
Net income 2024 * - 0 0 Net income 2025 * -3M -1.96M -163M EV / Sales 2024 * 1.41 x
Net cash position 2024 * 1.7M 1.11M 92.59M Net Debt 2025 * 1M 653K 54.46M EV / Sales 2025 * 1.3 x
P/E ratio 2024 *
-62.5 x
P/E ratio 2025 *
-12.5 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 64.99%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Little Green Pharma Ltd

1 day-3.85%
1 week-7.41%
Current month-10.71%
1 month-7.41%
3 months-13.79%
6 months-19.35%
Current year-10.71%
More quotes
1 week
0.13
Extreme 0.125
0.14
1 month
0.13
Extreme 0.125
0.15
Current year
0.12
Extreme 0.12
0.16
1 year
0.12
Extreme 0.12
0.21
3 years
0.12
Extreme 0.12
0.97
5 years
0.12
Extreme 0.12
1.02
10 years
0.12
Extreme 0.12
1.02
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Founder - 29/17/29
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chairman 71 13/18/13
Director/Board Member - 13/18/13
Director/Board Member - 19/18/19
More insiders
Date Price Change Volume
26/24/26 0.125 -3.85% 89,025
24/24/24 0.13 -3.70% 66,623
23/24/23 0.135 +3.85% 36,227
22/24/22 0.13 -3.70% 184,398
19/24/19 0.135 -3.57% 118,405

Delayed Quote Australian S.E., April 26, 2024 at 11:40 am IST

More quotes
Little Green Pharma Ltd is a global, vertically integrated and geographically diverse medicinal cannabis business with operations from cultivation and production through to manufacturing and distribution. The Company has two global production sites for the manufacture of its own-branded and white-label ranges of Good Manufacturing Practice (GMP)-grade medicinal cannabis products, being a 21,500 square meters cultivation and 4,000 square meters GMP manufacturing facility capable of producing over 30 tons of medicinal cannabis biomass per annum located in Denmark (EU) and an indoor cultivation and manufacturing facility located in Western Australia capable of producing three tons of medicinal cannabis biomass per annum. The Company focuses on patient access in the global medicinal cannabis market and is actively engaged in promoting education and outreach programs, as well as participating in clinical investigations and research projects to develop new delivery systems.
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.125 AUD
Average target price
0.17 AUD
Spread / Average Target
+36.00%
Consensus

Annual profits - Rate of surprise